# published open access (podcasts) — RSS Amplifier Recent posts from the 1 feeds in the RSS Amplifier directory that cover published open access. Page: Feed: --- ## [Vodcast on Real-World Comparative OS and PFS of CDK4/6 Inhibitors Plus an AI in the P-VERIFY Study](https://podcastb063dc.podigee.io/126-new-episode) _2026-08-06 · Adis Journal Podcasts_ In this podcast, Hope S. Rugo from the Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA, USA provides an overview of two recent publications reporting overall survival (OS) and real-world progression-free survival (rwPFS) results from P-VERIFY, a retrospective comparative effectiveness study of CDK4/6 inhibitors plus an aromatase… [Listen](https://audio.podigee-cdn.net/2565689-m-802305f332b20b5136f774ac9ec1b9d1.mp3?source=feed) ## [Subcutaneous Amivantamab and Lazertinib in PALOMA-3: Efficacy, Safety, and Administration: A Vodcast](https://podcastb063dc.podigee.io/125-new-episode) _2026-08-06 · Adis Journal Podcasts_ In this podcast, Danny Nguyen from the Department of Medical Oncology & Therapeutics Research, City of Hope, Huntington Beach, CA, USA discusses clinical considerations for subcutaneous amivantamab dosing and administration, including premedications, prophylactic measures, dose modifications, management of adverse reactions, and switching between IV and SC amivantamab. This podcast is published… [Listen](https://audio.podigee-cdn.net/2565098-m-f24f0f65021b2017e2f785ba9aab06a7.mp3?source=feed) ## [Revolutionizing 2L+ Myeloma: A Podcast on the New Era of BCMA-Targeted Bispecific Antibody Therapies](https://podcastb063dc.podigee.io/124-revolutionizing-2l-myeloma-a-podcast-on-the-new-era-of-bcma-targeted-bispecific-antibody-therapies) _2026-07-31 · Adis Journal Podcasts_ In this podcast, 2 leading haematologists discuss the unmet needs in multiple myeloma in the second-line setting and beyond, considerations for treatment decisions, and the evolving treatment landscape with a focus on B-cell maturation antigen-targeted bispecific antibodies, a rapidly advancing class of treatments in this setting. This podcast is published open access in Advances in Therapy and is… [Listen](https://audio.podigee-cdn.net/2561336-m-c26e99c27550a2608944562510980354.mp3?source=feed) ## [Beyond Typical AMD: A Vodcast Exploring the Clinical and Therapeutic Landscape of PCV](https://podcastb063dc.podigee.io/123-beyond-typical-amd-a-vodcast-exploring-the-clinical-and-therapeutic-landscape-of-pcv) _2026-07-31 · Adis Journal Podcasts_ This podcast is published open access in Advances in Therapy and is fully citeable. You can access the original published podcast article through the XX website and by using this link: https://link.springer.com/article/10.1007/s12325-026-03717-x. All conflicts of interest can be found online. This podcast is intended for medical professionals. Open Access: This podcast is licensed under a Creative… [Listen](https://audio.podigee-cdn.net/2561162-m-f0931298962bd5b8de55fbf7ab70670c.mp3?source=feed) ## [The Alternative Complement Pathway in IgA Nephropathy: A Podcast for Advanced Practice Providers](https://podcastb063dc.podigee.io/122-the-alternative-complement-pathway-in-iga-nephropathy-a-podcast-for-advanced-practice-providers) _2026-07-31 · Adis Journal Podcasts_ The Alternative Complement Pathway in IgA Nephropathy: A Podcast for Advanced Practice Providers This podcast is published open access in Advances in Therapy and is fully citeable. You can access the original published podcast article through the journal's website and by using this link: https://link.springer.com/article/10.1007/s12325-026-03680-7. All conflicts of interest can be found online.… [Listen](https://audio.podigee-cdn.net/2561143-m-1b87037616e4cc74b8f099bcf6a7aa55.mp3?source=feed) ## [Emerging role of PD-(L)1/VEGF bispecific antibodies for advanced renal cell carcinoma treatment](https://podcastb063dc.podigee.io/121-emerging-role-of-pd-l-1-vegf-bispecific-antibodies-for-advanced-renal-cell-carcinoma-treatment) _2026-06-29 · Adis Journal Podcasts_ Podcast on the Emerging Role of PD-(L)1/VEGF Bispecific Antibodies in the Evolving Advanced Renal Cell Carcinoma Treatment Landscape In this podcast, the authors discuss existing clinical evidence with bispecific antibodies in other cancers and explore the rationale for evaluating the antitumor activity of PD-(L)1/VEGF bispecifics, either as monotherapy or in conjunction with other treatments in… [Listen](https://audio.podigee-cdn.net/2532661-m-c1938d5083bda534058f98fe0fd2aa01.mp3?source=feed) ## [Obesity, Liver Disease, and the Patient Voice: A Clinical Dialogue Podcast](https://podcastb063dc.podigee.io/120-obesity-liver-disease-and-the-patient-voice-a-clinical-dialogue-podcast) _2026-06-09 · Adis Journal Podcasts_ This podcast is published open access in Advances in Therapy and is fully citeable. You can access the original published podcast article through the Advances in Therapy website and by using this link: https://link.springer.com/article/10.1007/s12325-026-03648-7. All conflicts of interest can be found online. This podcast is intended for medical professionals. Open Access This podcast is licensed… [Listen](https://audio.podigee-cdn.net/2516215-m-29aebf6152686ace3b087e1b92802ff6.mp3?source=feed) ## [HER2-Mutant Non-Small Cell Lung Cancer Podcast: Finding Patients (Episode 2)](https://podcastb063dc.podigee.io/119-new-episode) _2026-05-13 · Adis Journal Podcasts_ In episode 2 in our podcast series, Vivek Subbiah from the Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA, and Martin Dietrich from the US Oncology Network and Cancer Care Centers of Brevard, Orlando, FL, USA focus on the critical challenge of identifying patients with HER2-mutant non-small cell lung cancer (NSCLC). This podcast is published open access in… [Listen](https://audio.podigee-cdn.net/2488416-m-34c513b18e603d9fa41c110385556a1a.mp3?source=feed) ## [HER2-mutant Non-small Cell Lung Cancer Podcast: Knowledge Is Power (Episode 1)](https://podcastb063dc.podigee.io/118-new-episode) _2026-05-13 · Adis Journal Podcasts_ In the first episode of our podcast series, Vivek Subbiah from the Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA, Martin Dietrich from the US Oncology Network and Cancer Care Centers of Brevard, Orlando, FL, USA, and Xiuning Le from the University of Texas MD Anderson Cancer Center, Houston, TX, USA introduce the emerging landscape of HER2-mutant non-small… [Listen](https://audio.podigee-cdn.net/2488407-m-ee78a9e85b34576763241c2bff9f64b4.mp3?source=feed) ## [Real SIMs for AI Agents (Sponsored)](https://crawlproof.com/a/Xd2lkBvcgJTx) _2026-05-13 · **Sponsored**_ Pass 2FA and verifications with real carrier numbers via our API. ## [Podcast 3: Collaborative Care to Improve Cardiovascular Outcomes in Type 2 Diabetes](https://podcastb063dc.podigee.io/117-podcast-3-collaborative-care-to-improve-cardiovascular-outcomes-in-type-2-diabetes) _2026-04-15 · Adis Journal Podcasts_ Podcast Episode 3: How Can Physicians Work Collaboratively to Improve Cardiovascular Outcomes in Patients with Type 2 Diabetes? This podcast is published open access in Diabetes Therapy and is fully citeable. You can access the original published podcast article through the Diabetes Therapy website and by using this link: https://link.springer.com/article/10.1007/s13300-026-01857-5. All conflicts… [Listen](https://audio.podigee-cdn.net/2453196-m-8195684150c92f02a980ef6e085b072b.mp3?source=feed)